Literature DB >> 11378347

Reduction in the local expression of complement component 6 (C6) and 7 (C7) mRNAs in oesophageal carcinoma.

R Oka1, T Sasagawa, I Ninomiya, K Miwa, H Tanii, K Saijoh.   

Abstract

Differential displays of tumour/normal pair specimens of human oesophagus identified complement component 7 (C7) as being enhanced in normal tissues, but remarkably reduced in carcinoma tissues. In situ hybridisation confirmed the localisation of C7 mRNA in normal oesophageal epithelial cells and its disappearance in tumour cells. When mRNA expressions of other components were examined by means of semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) in 10 tumour/normal pair specimens, significant reductions in C6 and C7 mRNAs were observed, while C3 and C5 mRNAs were enhanced in both normal and tumour tissues. A similar reduction was observed in colon and kidney cancers using the tumour/normal expression array analysis. Gene deletion of C7 was not found in the cell lines by Southern blot analysis. Our findings suggest a possible relationship between oesophageal tumorigenesis and reduced expression of C6 and C7 mRNAs, which is probably caused by a change in gene expression regulation and not by genetic loss of the locus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378347     DOI: 10.1016/s0959-8049(01)00089-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  17 in total

1.  Toward predicting metastatic progression of melanoma based on gene expression data.

Authors:  Yuanyuan Li; Juno M Krahn; Gordon P Flake; David M Umbach; Leping Li
Journal:  Pigment Cell Melanoma Res       Date:  2015-04-24       Impact factor: 4.693

2.  Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.

Authors:  Z Wang; J Liao; S Wu; C Li; J Fan; Z Peng
Journal:  Cancer Gene Ther       Date:  2016-05-13       Impact factor: 5.987

3.  Development and validation of an immune prognostic signature for ovarian carcinoma.

Authors:  Seema Khadirnaikar; Pranjal Kumar; Sudhanshu Kumar Shukla
Journal:  Cancer Rep (Hoboken)       Date:  2019-02-19

4.  Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.

Authors:  Suhaida A Selamat; Brian S Chung; Luc Girard; Wei Zhang; Ying Zhang; Mihaela Campan; Kimberly D Siegmund; Michael N Koss; Jeffrey A Hagen; Wan L Lam; Stephen Lam; Adi F Gazdar; Ite A Laird-Offringa
Journal:  Genome Res       Date:  2012-05-21       Impact factor: 9.043

5.  Gene expression profiling of human ovarian tumours.

Authors:  S Biade; M Marinucci; J Schick; D Roberts; G Workman; E H Sage; P J O'Dwyer; V A Livolsi; S W Johnson
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640

6.  Gene Variations of Sixth Complement Component Affecting Tacrolimus Metabolism in Patients with Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Jian-Hua Liao; Chang-Can Li; Shao-Han Wu; Jun-Wei Fan; Hai-Tao Gu; Zhao-Wen Wang
Journal:  Chin Med J (Engl)       Date:  2017-07-20       Impact factor: 2.628

7.  Complement component 7 (C7), a potential tumor suppressor, is correlated with tumor progression and prognosis.

Authors:  Lisha Ying; Fanrong Zhang; Xiaodan Pan; Kaiyan Chen; Nan Zhang; Jiaoyue Jin; Junzhou Wu; Jianguo Feng; Herbert Yu; Hongchuan Jin; Dan Su
Journal:  Oncotarget       Date:  2016-12-27

8.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07

9.  Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells.

Authors:  Qunying Hong; Chun-I Sze; Sing-Ru Lin; Ming-Hui Lee; Ruei-Yu He; Lori Schultz; Jean-Yun Chang; Shean-Jen Chen; Robert J Boackle; Li-Jin Hsu; Nan-Shan Chang
Journal:  PLoS One       Date:  2009-06-01       Impact factor: 3.240

10.  Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury.

Authors:  Hal X Nguyen; Manuel D Galvan; Aileen J Anderson
Journal:  J Neuroinflammation       Date:  2008-06-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.